Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson’s community catalyzed the founding of Charco and how #innovative medical devices and software can improve the ...

A new early-stage investment fund has completed its first investment with a six-figure cash injection for a medtech firm. The Imperial College Innovations Fund (ICIF) has invested £205k into Charco ...

With a waiting list of some 90,000 people, startup company Charco Neurotech Ltd. is seeing growing demand for its Cue1 device which has shown to reduce the symptoms of Parkinson’s disease in patients ...

A 24 month Knowledge Transfer Partnership project between WIPH Preventive Neurology Unit researchers and industry partner, Charco Neurotech, will test the feasibility of CUE1, a novel medical device ...

The term ‘neurotech’ refers to neurotechnology that aims to measure and regulate the state of the human brain. Although there are currently many neurotech products available for purchase, the ...